WEKO3
アイテム
{"_buckets": {"deposit": "1362b27c-0975-4ab3-a606-11b7eecd642c"}, "_deposit": {"created_by": 1, "id": "65334", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "65334"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00065334", "sets": ["29"]}, "author_link": ["643800", "643804", "643801", "643803", "643799", "643802"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2012-04-24", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Venous thromboembolism(VIE), which includes deep vein thrombosis(DVT) and pulmonaly embolism(PE), is a major complication of cancer and one of the leading causes of death among cancer patients.\nApproximately 20% of patients diagnosed with pancreatic adenocarcinoma develop venous thromboembolism, contributing to the poor prognosis of this disease. A small phase II trial suggested longer survival with the addition of low molecular weight heparin (LMWH) to chemotherapy. lf VTE is diagnosed or predicted in pat1ents treated by carbon-ion at early phase, severe VTE will be prevented by administration of anticoagulants. The pulpose of this study is to evaluate risk Risk of venous thromboembolism with Carbon-ion radiotherapy in cancer patients.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "平成23年度HIMAC共同利用研究成果発表会", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "山田, 滋"}], "nameIdentifiers": [{"nameIdentifier": "643799", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠藤, 誠"}], "nameIdentifiers": [{"nameIdentifier": "643800", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "遠藤, 悟史"}], "nameIdentifiers": [{"nameIdentifier": "643801", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 滋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "643802", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠藤 誠", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "643803", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "遠藤 悟史", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "643804", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "重粒子線治療のおける血栓症寒栓症に関する研究", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "重粒子線治療のおける血栓症寒栓症に関する研究"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/65334", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-11-18"}, "publish_date": "2013-11-18", "publish_status": "0", "recid": "65334", "relation": {}, "relation_version_is_last": true, "title": ["重粒子線治療のおける血栓症寒栓症に関する研究"], "weko_shared_id": -1}
重粒子線治療のおける血栓症寒栓症に関する研究
https://repo.qst.go.jp/records/65334
https://repo.qst.go.jp/records/6533452a87682-987c-4a28-9be8-eb0975b38505
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-11-18 | |||||
タイトル | ||||||
タイトル | 重粒子線治療のおける血栓症寒栓症に関する研究 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
山田, 滋
× 山田, 滋× 篠藤, 誠× 遠藤, 悟史× 山田 滋× 篠藤 誠× 遠藤 悟史 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Venous thromboembolism(VIE), which includes deep vein thrombosis(DVT) and pulmonaly embolism(PE), is a major complication of cancer and one of the leading causes of death among cancer patients. Approximately 20% of patients diagnosed with pancreatic adenocarcinoma develop venous thromboembolism, contributing to the poor prognosis of this disease. A small phase II trial suggested longer survival with the addition of low molecular weight heparin (LMWH) to chemotherapy. lf VTE is diagnosed or predicted in pat1ents treated by carbon-ion at early phase, severe VTE will be prevented by administration of anticoagulants. The pulpose of this study is to evaluate risk Risk of venous thromboembolism with Carbon-ion radiotherapy in cancer patients. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 平成23年度HIMAC共同利用研究成果発表会 | |||||
発表年月日 | ||||||
日付 | 2012-04-24 | |||||
日付タイプ | Issued |